Information for Healthcare Providors
Provent Therapy Has Been Validated in Multiple Peer Reviewed Publications
Provent Therapy is an new treatment option for OSA especialy for patients who have rejected or are non-compliant with CPAP.
- Provent Therapy Provides clinically significant results (reduced AHI (apnea-hypopnea index), ODI (oxygen desaturation index), daytime sleepiness and snoring)
- Works across mild, moderate and severe OSA
- Is well tolerated by patients
Key Publications
- A Novel Nasal Expiratory Positive Airway Pressure (EPAP) Device for the Treatment of Obstructive Sleep Apnea: A Randomized Controlled Trial Berry, RB, Kryger, MH, Massie, CA [Sleep 2011;34 (4):479-485](19 Center, 3 Month, Randomized Controlled Trial)
- Long term use of a nasal expiratory positive airway pressure (EPAP) device as a treatment for obstructive sleep apneaKryger MH, Berry RB, Massie CA. [SLEEP Abstract Supplement, 2011 (34):A118](13 Center, Long Term Efficacy Study)
- Nasal expiratory positive airway pressure (EPAP) for the treatment of obstructive sleep apnea: A review of clinical studies of Provent TherapyDoshi, R, Westbrook P [Respiratory Therapy Vol.6 No.4, 2011:6(4):45-49](Summary of All Peer Reviewed Studies)
Publications
- Changes in lung volume and upper airway using MRI during application of nasal expiratory positive airway pressure in patients with sleep disordered breathing.Braga CW, Chen Q, Burschtin O, et al. [Journal of Applied Physiology 2011;111:1400-1409]
- Predictors of response to a nasal expiratory resistor device and its potential mechanisms of action for treatment of obstructive sleep apnea Patel AV, Hwang D, Masdeu MJ et al. [Journal of Clinical Sleep Medicine 2011;7(1):13-22]
- A convenient expiratory positive airway pressure nasal device for the treatment of sleep apnea in patients non-adherent with continuous positive airway pressure Walsh JK, Griffin KS, Forst EH, et al. [Sleep Medicine 2011;12:147-52]
- A multicenter, prospective study of a novel nasal EPAP device in the treatment of obstructive sleep apnea. Efficacy and 30-day adherence Rosenthal L, Massie CA, Dolan DC, et al. [Journal of Clinical Sleep Medicine 2009;5:532-37]
- A pilot evaluation of a nasal expiratory resistance device for the treatment of obstructive sleep apneaColrain IM, Brooks S, Black J. [Journal of Clinical Sleep Medicine 2008;4(5):426-433]
- Nasal expiratory positive airway pressure (EPAP) for the treatment of obstructive sleep apnea: A review of clinical studies of Provent TherapyDoshi, R, Westbrook P [Respiratory Therapy Vol.6 No.4, 2011:6(4):45-49]
- Optimizing Patient Compliance on Nasal EPAP (Provent Therapy): The Role of the Healthcare ProviderDoshi, R, Heller D [Respiratory Therapy Vol.7 No.2, 2012:7(2):34-36]
- Long term use of a nasal expiratory positive airway pressure (EPAP) device as a treatment for obstructive sleep apneaKryger MH, Berry RB, Massie CA. [Journal of Clinical Sleep Medicine 2011; 7:5:449-453]
- A Novel Nasal Expiratory Positive Airway Pressure (EPAP) Device for the Treatment of Obstructive Sleep Apnea: A Randomized Controlled Trial Berry, RB, Kryger, MH, Massie, CA [Sleep 2011;34 (4):479-485]